The trademark NEOBASE was filed by Abiogen Pharma S.p.A., a corporation established under the laws of the Italian Republic (the "Applicant"). The application was published for oppositions on October 5, 2023, and received one opposition filed on December 26, 2023 by Neoss Limited on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. the opponent was represented by HGF B.V. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 26, 2023
The application was filed in Italian, and Italian was also language of all opposition proceedings (English was selected as the second language).